$22M Award Won't Stop Cordis' Infringement, Fed. Circ. Told
Spectralytics Inc. told a Federal Circuit panel on Monday that a $22 million verdict against Cordis Corp. and stent manufacturer Norman Noble Inc. won't deter the companies from infringing on smaller...To view the full article, register now.
Already a subscriber? Click here to view full article